Premium
Buscopan® for the treatment of pain after laparoscopic sterilisation
Author(s) -
Habib A.,
Sharpe P.,
Anderson S.,
Francis S.,
Davidson A. C.,
Smith G.
Publication year - 2001
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1046/j.1365-2044.2001.01528-2.x
Subject(s) - medicine , analgesic , anesthesia , placebo , nausea , clips , vomiting , saline , surgery , incidence (geometry) , laparoscopic surgery , laparoscopy , pathology , physics , alternative medicine , optics
We investigated the effect of Buscopan® 20 mg, given at the end of surgery, on analgesic requirements in 44 ASA I and II patients presenting as day cases for laparoscopic sterilisation using Filshie clips. Patients were randomly allocated to receive either intravenous Buscopan 20 mg or saline placebo at the end of surgery. There was no significant difference in pain scores, analgesic requirements or the incidence of nausea and vomiting between the two groups. We conclude that intravenous Buscopan 20 mg was not effective for pain relief following laparoscopic sterilisation.